Latest News for: Pharmaceutical sources

Edit

Drug industry treads carefully after stunning RFK Jr. nomination

The Hill 20 Nov 2024
... shock waves through the pharmaceutical industry ... Multiple sources said one of the top concerns among pharmaceutical companies is that a Kennedy-run HHS would try to somehow change the user fee system.
Edit

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

ACCESSWIRE 20 Nov 2024
Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment MIAMI, FL / ACCESSWIRE / November 20, 2024 / MIRA Pharmaceuticals, Inc.
Edit

Transforming Lives Through Comprehensive Wellness Solutions

GetNews 20 Nov 2024
Treatments include hormone optimization, peptide therapy, customized IV therapies, and more—many of which are made possible through their in-house American Wellness Pharmacy, a trusted source for pharmaceutical-grade peptides.
Edit

Nvidia to report third-quarter earnings after the bell

NBC Bay Area 20 Nov 2024
Revenue ... 75 cents, adjusted ... This mental hack can turn your everyday routine into a source of ‘joy and satisfaction' ... Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook ... .
Edit

Indian Companies Refuse to Export Raw Materials for Medicines to Syria

The Syrian Observer 19 Nov 2024
... India accounts for approximately 65% of Syria’s total pharmaceutical imports, with cancer medications, immunosuppressants, and vaccines being among the most significant products sourced from India.
Edit

CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the ...

ACCESSWIRE 18 Nov 2024
HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc ... Sandra Silberman, MD, PhD, Chief Medical Officer of CNS Pharmaceuticals Program Code ... About CNS Pharmaceuticals, Inc ... CNS Pharmaceuticals, Inc.
Edit

CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)

Pharmiweb 18 Nov 2024
HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc ... Sandra Silberman, MD, PhD, Chief Medical Officer of CNS Pharmaceuticals ... About CNS Pharmaceuticals, Inc ... SOURCE. CNS Pharmaceuticals, Inc.
Edit

Why Is Mannitol Important in Vaccine Formulation?

Pharmiweb 18 Nov 2024
Mannitol is widely used in the biomedical and pharmaceutical industries due to its unique properties and potential applications. Production and Sources of Mannitol ... [3] Application of Mannitol in Pharmaceutical Formulation ... Article Source References.
Edit

Bausch Health and Salix to Present at the American Association for the Study of Liver ...

ACCESSWIRE 18 Nov 2024
BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes ... ### �2024 Salix Pharmaceuticals or its affiliates. XIF.0210.USA.24 SOURCE.
Edit

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

Pharmiweb 18 Nov 2024
BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes ... ©2024 Salix Pharmaceuticals or its affiliates ... SOURCE.
Edit

Opulence Capital to Establish Saudi Arabia’s Premier Co-Polymer 2A Facility in Alliance with Multinational Coalition ...

GetNews 18 Nov 2024
The new Co-Polymer 2A factory will prioritize close collaboration with major pharmaceutical companies across the Middle East, Africa, and Asia, offering them a local and reliable source of essential ...
Edit

NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in ...

ACCESSWIRE 18 Nov 2024
Z�RICH, SWITZERLAND / ACCESSWIRE / November 18, 2024 / NLS Pharmaceutics Ltd ... About NLS Pharmaceutics Ltd. ... Investor Relations Contact InvestorRelations@nls-pharma.com www.nlspharma.com SOURCE.
Edit

NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders

Pharmiweb 18 Nov 2024
ZÜRICH, SWITZERLAND / ACCESSWIRE / November 18, 2024 / NLS Pharmaceutics Ltd ... About NLS Pharmaceutics Ltd... NLS Pharmaceutics is a global biopharmaceutical company dedicated ... SOURCE. NLS Pharmaceutics AG.
Edit

The Economist | The Next Big Thing!

Gladewater Mirror 18 Nov 2024
... (with better imaging, devices, and pharmaceuticals), energy security (through advances which have increased production potential across a spectrum of sources), and other aspects of our wellbeing.

Most Viewed

×